CODE. NDC DESCRIPTION. PROCEDURE COD PROCEDURE DESCRIPTION. EFFECTIVE RECLAST. J3489. ZOLEDRONIC ACID 1MG
Zoledronic Acid (Zometa Reclast ) Medicare Advantage Policy Guideline Author: UnitedHealthcare Subject: This policy addresses the use of zoledronic acid (Zometa Reclast ). Applicable Procedure Code: J3489. Created Date: 6:
Codes: J Code(s). Code. Description. J0897. Injection, denosumab, 1 mg. J3489 Reclast [package insert]. East Hanover, NJ: Novartis Pharmaceuticals
Official answer: Evenity J code is J3111. J codes are used for What's the difference between Prolia and Reclast? How do you give a
o HCPCS J-code or other code:______ o Administering Provider/Facility Reclast Xgeva Zoledronic Acid Zometa. Dose Frequency
J3247: Permanent J-code for the intravenous (IV) formulation of COSENTYX (secukinumab) . Effective J, for all sites of care If COSENTYX is administered on or after J, the permanent J-code replaces the miscellaneous J-code, J3590.
If a claim is submitted using an unlisted J-Code such as J3490 and a valid zoledronic acid (Reclast). J3489. OSTEOPOROSIS. NO zoledronic acid (Zometa).
Under the Healthcare Common Procedure Coding System (HCPCS), the BRIUMVI J-Code (J2329) will become effective J. J-Code for BRIUMVI
Reclast is contraindicated for patients with chronic renal failure. Kim J. Robertson. Febru. Regulatory Project Manager. Date.
R.